BlackRock Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
MNA
BlackRock Investment Management's NVS Position: Q4 2016 in Review
BlackRock Investment Management increased its Novartis (NVS) stake by 6.8% in Q4 2016, buying an estimated $3.53M and bringing the position to 853,473 shares worth $55.7M. The position accounts for 0.06% of the portfolio, ranked #283.
BlackRock Investment Management first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $56.5M in Q3 2016. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.
- BlackRock Investment Management held 853,473 shares of Novartis worth $55.7M as of Q4 2016.
- BlackRock Investment Management bought 54,437 Novartis shares in Q4 2016, an estimated $3.53M.
- Novartis made up 0.06% of BlackRock Investment Management's portfolio in Q4 2016, its #283 holding.
- BlackRock Investment Management first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
- BlackRock Investment Management's Novartis position peaked at $56.5M in Q3 2016.
- 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.